As currently written, NAFTA 2.0 requires signatory countries to give pharma corporations at least a 10-year monopoly period on biologic drugs, which they often price at over $100,000 per person per year. This is referred to by many cancer patients as a “Death Sentence Clause” because it makes it impossible for them to get more affordable generic medications. NAFTA 2.0 also expands the definition of “biologic” so that more drugs are covered by the monopoly period. Trump is right – Big Pharma is getting away with murder. And he is helping them.
At least 25% of diabetes patients rationing insulin as drug costs continue to skyrocket
THE HILL REPORTS:
Congress must get pharma out of NAFTA 2.0
By Alex Lawson and Linda Benesch, Opinion Contributors — 10/11/19 04:30 PM EDT 28